Business Description
Guardant Health Inc
NAICS : 621511
SIC : 8071
ISIN : US40131M1099
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.84 | |||||
Equity-to-Asset | 0.04 | |||||
Debt-to-Equity | 19.73 | |||||
Debt-to-EBITDA | -3.25 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.47 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.6 | |||||
3-Year EBITDA Growth Rate | -18.8 | |||||
3-Year EPS without NRI Growth Rate | -18.1 | |||||
3-Year FCF Growth Rate | -24 | |||||
3-Year Book Growth Rate | -53.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 29.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 21.1 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.81 | |||||
9-Day RSI | 94.12 | |||||
14-Day RSI | 74.36 | |||||
6-1 Month Momentum % | -39.19 | |||||
12-1 Month Momentum % | -38.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.95 | |||||
Quick Ratio | 5.66 | |||||
Cash Ratio | 5.13 | |||||
Days Inventory | 94.27 | |||||
Days Sales Outstanding | 52.7 | |||||
Days Payable | 95.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | 0.52 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.37 | |||||
Operating Margin % | -87.85 | |||||
Net Margin % | -76.34 | |||||
FCF Margin % | -50.03 | |||||
ROE % | -327.6 | |||||
ROA % | -26.67 | |||||
ROIC % | -98.51 | |||||
ROC (Joel Greenblatt) % | -146.84 | |||||
ROCE % | -30.17 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.94 | |||||
PB Ratio | 45.49 | |||||
Price-to-Tangible-Book | 54.34 | |||||
EV-to-EBIT | -7.3 | |||||
EV-to-Forward-EBIT | -8.25 | |||||
EV-to-EBITDA | -8.07 | |||||
EV-to-Forward-EBITDA | -10.45 | |||||
EV-to-Revenue | 5.53 | |||||
EV-to-Forward-Revenue | 4.92 | |||||
EV-to-FCF | -11.11 | |||||
Earnings Yield (Greenblatt) % | -13.7 | |||||
FCF Yield % | -9.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Guardant Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 10,331.212 | ||
EPS (TTM) (MXN) | -67.112 | ||
Beta | 1.65 | ||
Volatility % | 56.38 | ||
14-Day RSI | 74.36 | ||
14-Day ATR (MXN) | 0.666561 | ||
20-Day SMA (MXN) | 314.928 | ||
12-1 Month Momentum % | -38.05 | ||
52-Week Range (MXN) | 293.83 - 662.5 | ||
Shares Outstanding (Mil) | 122.37 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Guardant Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Guardant Health Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Guardant Health Inc Frequently Asked Questions
What is Guardant Health Inc(MEX:GH)'s stock price today?
When is next earnings date of Guardant Health Inc(MEX:GH)?
Does Guardant Health Inc(MEX:GH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |